Literature DB >> 8815107

Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group.

M E Brandt1, L C Hutwagner, L A Klug, W S Baughman, D Rimland, E A Graviss, R J Hamill, C Thomas, P G Pappas, A L Reingold, R W Pinner.   

Abstract

To improve understanding of the epidemiology of cryptococcal disease, we analyzed the multilocus genotype distribution of 358 Cryptococcus neoformans isolates obtained from 251 patients through active surveillance in four U.S. geographic areas from 1992 through 1994. Isolates of the predominant enzyme electrophoretic type (ET), ET-1, were recovered in significantly greater proportion from Atlanta, Ga., Houston, Tex., and all major metropolitan areas of Alabama than from San Francisco, Calif. ET-2 and ET-7 complex (serotype AD) isolates were recovered predominantly from San Francisco. ET-3 was recovered less frequently from San Francisco than from the three other locations. These findings may reflect geographic differences in exposure to environmental strains or the identification of previously unrecognized C. neoformans clusters. Analysis by random amplified polymorphic DNA-PCR subtyping further divided 67 ET-1 isolates into 19 additional subtypes, none of which could be associated with a particular geographic region. Multiple isolates from the same patient always revealed the same multilocus enzyme electrophoresis and random amplified polymorphic DNA subtypes. No differences in subtype distribution were found when isolates from AIDS patients were compared with those from persons without or with another underlying disease, although one C. noeformans var. gattii isolate was obtained from an AIDS patient. When body site distribution was analyzed, ET-4 was disproportionately recovered from skin or surface body sites. Evidence for linkage disequilibrium in this fungal population suggests that virulent C. neoformans possesses a clonal population structure. Continued application of molecular subtyping methods will be useful in tracking the source, transmission, and relative virulence of different C. neoformans strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815107      PMCID: PMC228916          DOI: 10.1128/jcm.34.4.912-917.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Cryptococcus neoformans var. gattii in a Brazilian AIDS patients.

Authors:  R Rozenbaum; A J Gonçalves; B Wanke; W Vieira
Journal:  Mycopathologia       Date:  1990-10       Impact factor: 2.574

2.  Development of DNA probes for early diagnosis and epidemiological study of cryptococcosis in AIDS patients.

Authors:  I Polacheck; G Lebens; J B Hicks
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Isolation of Cryptococcus neoformans gattii from a patient with AIDS in southern California.

Authors:  M N Clancy; J Fleischmann; D H Howard; K J Kwon-Chung; R Y Shimizu
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

4.  Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans.

Authors:  A Varma; K J Kwon-Chung
Journal:  J Gen Microbiol       Date:  1989-12

5.  Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations.

Authors:  W F Bibb; B G Gellin; R Weaver; B Schwartz; B D Plikaytis; M W Reeves; R W Pinner; C V Broome
Journal:  Appl Environ Microbiol       Date:  1990-07       Impact factor: 4.792

6.  Are eukaryotic microorganisms clonal or sexual? A population genetics vantage.

Authors:  M Tibayrenc; F Kjellberg; J Arnaud; B Oury; S F Brenière; M L Dardé; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 7.  Cryptococcal meningitis in the acquired immunodeficiency syndrome.

Authors:  L A Panther; M A Sande
Journal:  Semin Respir Infect       Date:  1990-06

8.  Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans.

Authors:  E D Spitzer; S G Spitzer
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

9.  Extensive allelic variation in Cryptococcus neoformans.

Authors:  A Casadevall; L F Freundlich; L Marsh; M D Scharff
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 10.  Cryptococcosis.

Authors:  J R Perfect
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

View more
  49 in total

1.  Monoclonal antibody 13F1 produces annular immunofluorescence patterns on Cryptococcus neoformans serotype AD isolates.

Authors:  W Cleare; M E Brandt; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 2.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure.

Authors:  S P Franzot; J S Hamdan; B P Currie; A Casadevall
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 4.  The evolution of sex: a perspective from the fungal kingdom.

Authors:  Soo Chan Lee; Min Ni; Wenjun Li; Cecelia Shertz; Joseph Heitman
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

5.  Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana.

Authors:  Anastasia P Litvintseva; Rameshwari Thakur; Rytas Vilgalys; Thomas G Mitchell
Journal:  Genetics       Date:  2005-12-01       Impact factor: 4.562

6.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Genotype-environment interactions of spontaneous mutations for vegetative fitness in the human pathogenic fungus Cryptococcus neoformans.

Authors:  Jianping Xu
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

8.  Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

Authors:  M E Brandt; M A Pfaller; R A Hajjeh; R J Hamill; P G Pappas; A L Reingold; D Rimland; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States.

Authors:  Naureen Iqbal; Emilio E DeBess; Ron Wohrle; Ben Sun; Randall J Nett; Angela M Ahlquist; Tom Chiller; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

10.  Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure.

Authors:  S Bertout; F Renaud; D Swinne; M Mallié; J M Bastide
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.